BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally. The company offers recombinant human insulin; oral diabetic drugs; strips for measuring sugar in blood, as well as Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes monitoring technology, as well as needles. BIOTON S.A. was founded in 1989 and is based in Ozar贸w Mazowiecki, Poland.
Stock data | 2024 | Change |
---|---|---|
Price | $0.8874532846795798 | N/A |
Market Cap | $76.20M | N/A |
Shares Outstanding | 85.86M | N/A |
Employees | 355.00 | N/A |